Cipla Ltd.
| BSE: 500087 | Sector: Health care |
| NSE: CIPLA | ISIN Code: INE059A01026 |
| BSE LIVE 15:43 | 17 Aug | 573.35 |
573.35 (%) |
OPEN
590.20 |
HIGH
592.40 |
LOW
571.10 |
| NSE 15:51 | 17 Aug | 573.20 |
-17.25 (-2.92%) |
OPEN
593.40 |
HIGH
594.00 |
LOW
569.90 |
| OPEN | 590.20 |
| PREVIOUS CLOSE | 0.00 |
| VOLUME | 112346 |
| 52-Week high | 621.90 |
| 52-Week low | 479.00 |
| P/E | 48.30 |
| Mkt Cap.(Rs cr) | 46,137 |
| Buy Price | 573.35 |
| Buy Qty | 45.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Cipla Ltd. (CIPLA) - Peer Group
| COMPANY | PRICE (In Rs) |
CHG (%) |
MKT CAP (Rs Cr) |
SALES (Rs Cr) |
PROFIT (Rs Cr) |
EPS (Rs) |
P/E (x) |
| Sun Pharma.Inds. | 488.60 | 117229.79 | 7136.96 | 1344.52 | 0.00 | - | |
| Cadila Health. | 481.80 | 49321.87 | 2478.20 | 410.40 | 6.78 | 71.06 | |
| Piramal Enterp. | 2718.80 | 46912.89 | 2245.75 | 247.46 | 32.49 | 83.68 | |
| Cipla | 573.35 | 46137.48 | 3582.00 | -60.86 | 11.87 | 48.30 | |
| Lupin | 954.10 | 43101.47 | 3869.58 | 359.12 | 53.47 | 17.84 | |
| Aurobindo Pharma | 703.50 | 41218.07 | 3678.75 | 518.33 | 27.70 | 25.40 | |
| Dr Reddy's Labs | 2010.00 | 33329.82 | 3333.20 | 56.80 | 58.36 | 34.44 | |
| Torrent Pharma. | 1303.90 | 22064.60 | 1374.00 | 188.00 | 35.52 | 36.71 | |
| Alkem Lab | 1819.50 | 0.46 | 21752.12 | 1251.40 | 136.96 | 62.21 | 29.25 |
| Glaxosmi. Pharma | 2385.05 | 20201.37 | 607.09 | 26.42 | 29.85 | 79.90 | |
| Biocon | 329.25 | 19755.00 | 927.40 | 97.70 | 7.21 | 45.67 | |
| Glenmark Pharma. | 620.05 | 17497.81 | 2363.00 | 333.38 | 71.55 | 8.67 | |
| Divi's Lab. | 645.50 | 17134.80 | 820.70 | 231.47 | 34.96 | 18.46 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
